In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As of close of business last night, Cue Health Inc’s stock clocked out at $0.12, down -5.20% from its previous closing price of $0.13. In other words, the price has decreased by -$5.20 from its previous closing price. On the day, 0.92 million shares were traded. HLTH stock price reached its highest trading level at $0.1359 during the session, while it also had its lowest trading level at $0.1206.
Ratios:
To gain a deeper understanding of HLTH’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.22 and its Current Ratio is at 2.54. In the meantime, Its Debt-to-Equity ratio is 0.19 whereas as Long-Term Debt/Eq ratio is at 0.17.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HLTH now has a Market Capitalization of 19441042 and an Enterprise Value of -13579308. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.27 while its Price-to-Book (P/B) ratio in mrq is 0.08. Its current Enterprise Value per Revenue stands at -0.191 whereas that against EBITDA is 0.062.
Stock Price History:
The Beta on a monthly basis for HLTH is 1.30, which has changed by -0.81143737 over the last 52 weeks, in comparison to a change of 0.2704494 over the same period for the S&P500. Over the past 52 weeks, HLTH has reached a high of $0.89, while it has fallen to a 52-week low of $0.13. The 50-Day Moving Average of the stock is -32.30%, while the 200-Day Moving Average is calculated to be -59.83%.
Shares Statistics:
It appears that HLTH traded 520.85K shares on average per day over the past three months and 476720 shares per day over the past ten days. A total of 155.30M shares are outstanding, with a floating share count of 136.34M. Insiders hold about 14.30% of the company’s shares, while institutions hold 39.56% stake in the company. Shares short for HLTH as of 1714435200 were 632888 with a Short Ratio of 1.22, compared to 1711584000 on 563522. Therefore, it implies a Short% of Shares Outstanding of 632888 and a Short% of Float of 0.53.
Earnings Estimates
Its stock is currently analyzed by 3.0 different market analysts. On average, analysts expect EPS of -$0.38 for the current quarter, with a high estimate of -$0.34 and a low estimate of -$0.4, while EPS last year was -$0.62. The consensus estimate for the next quarter is -$0.29, with high estimates of -$0.19 and low estimates of -$0.36.
Analysts are recommending an EPS of between -$0.84 and -$1.32 for the fiscal current year, implying an average EPS of -$1.1. EPS for the following year is -$0.65, with 3.0 analysts recommending between -$0.39 and -$1.09.
Revenue Estimates
In the current quarter, 2 analysts expect revenue to total $10.1M. It ranges from a high estimate of $10.3M to a low estimate of $9.91M. As of the current estimate, Cue Health Inc’s year-ago sales were $24.77MFor the next quarter, 2 analysts are estimating revenue of $9.55M. There is a high estimate of $9.7M for the next quarter, whereas the lowest estimate is $9.4M.
A total of 3 analysts have provided revenue estimates for HLTH’s current fiscal year. The highest revenue estimate was $61.35M, while the lowest revenue estimate was $54.59M, resulting in an average revenue estimate of $56.98M. In the same quarter a year ago, actual revenue was $70.94MBased on 3 analysts’ estimates, the company’s revenue will be $109.79M in the next fiscal year. The high estimate is $117.74M and the low estimate is $100M.
